Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Control Release. 2022 Jan 22;343:267–276. doi: 10.1016/j.jconrel.2022.01.024

Figure 5: Intratumoral retention of CpG delivered by an ELP depot.

Figure 5:

(A) Representative fluorescence molecular tomography (FMT) images of mice bearing orthotopic 4T1 tumors injected with fluorescently labeled CpG alone (n=3), an ELP depot (n=3), or an ELP-K12 depot (n=6), or (B) I.t. retention of CpG delivered with or without an ELP depot over time. (C) Area under the curve (AUC) for the i.t. retention of CpG from the three different treatments. *p < 0.05 (ANOVA, Tukey).